
Herbert Goldstein
Examiner (ID: 18423)
| Most Active Art Unit | 2608 |
| Art Unit(s) | 2607, 2403, 2616, 2613, 2214, 2605, 2611, 2608 |
| Total Applications | 1485 |
| Issued Applications | 1358 |
| Pending Applications | 2 |
| Abandoned Applications | 125 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18449582
[patent_doc_number] => 20230190858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => Treatment for Diseases Caused By RNA Viruses
[patent_app_type] => utility
[patent_app_number] => 18/169473
[patent_app_country] => US
[patent_app_date] => 2023-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169473
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169473 | Treatment for diseases caused by RNA virus SARS-CoV-2 | Feb 14, 2023 | Issued |
Array
(
[id] => 18597627
[patent_doc_number] => 20230272424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 18/165138
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165138
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/165138 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | Feb 5, 2023 | Abandoned |
Array
(
[id] => 20240991
[patent_doc_number] => 12421299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Expression of FC-containing proteins
[patent_app_type] => utility
[patent_app_number] => 18/156215
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 20343
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18156215
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/156215 | Expression of FC-containing proteins | Jan 17, 2023 | Issued |
Array
(
[id] => 18628516
[patent_doc_number] => 20230287381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/069651
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 151084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069651
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069651 | PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF | Dec 20, 2022 | Pending |
Array
(
[id] => 18485197
[patent_doc_number] => 20230212524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Methods and Compositions for Rapid Generation of Single and Multiplexed Reporters in Cells
[patent_app_type] => utility
[patent_app_number] => 18/080093
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18080093
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/080093 | Methods and compositions for rapid generation of single and multiplexed reporters in cells | Dec 12, 2022 | Issued |
Array
(
[id] => 18537821
[patent_doc_number] => 20230242923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => GENERATION OF ACYL AMINO ACIDS
[patent_app_type] => utility
[patent_app_number] => 18/063629
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063629
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063629 | GENERATION OF ACYL AMINO ACIDS | Dec 7, 2022 | Pending |
Array
(
[id] => 18726264
[patent_doc_number] => 20230340532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 18/061000
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061000 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | Dec 1, 2022 | Abandoned |
Array
(
[id] => 18468839
[patent_doc_number] => 20230203121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => Incretin Analogs and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/057398
[patent_app_country] => US
[patent_app_date] => 2022-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057398
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057398 | Incretin analogs and uses thereof | Nov 20, 2022 | Issued |
Array
(
[id] => 18581603
[patent_doc_number] => 20230263855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => PEPTIDE-POLYNUCLEOTIDE-HYALURONIC ACID NANOPARTICLES AND METHODS FOR POLYNUCLEOTIDE TRANSFECTION
[patent_app_type] => utility
[patent_app_number] => 18/056823
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056823
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056823 | PEPTIDE-POLYNUCLEOTIDE-HYALURONIC ACID NANOPARTICLES AND METHODS FOR POLYNUCLEOTIDE TRANSFECTION | Nov 17, 2022 | Pending |
Array
(
[id] => 18321113
[patent_doc_number] => 20230119241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHOD FOR SOLUBLE EXPRESSION AND PURIFICATION OF HYDROPHOBIN
[patent_app_type] => utility
[patent_app_number] => 18/056708
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056708
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056708 | Method for soluble expression and purification of hydrophobin | Nov 16, 2022 | Issued |
Array
(
[id] => 18628579
[patent_doc_number] => 20230287452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR
[patent_app_type] => utility
[patent_app_number] => 18/054786
[patent_app_country] => US
[patent_app_date] => 2022-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18054786
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/054786 | METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR | Nov 10, 2022 | Abandoned |
Array
(
[id] => 18452017
[patent_doc_number] => 20230193296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => MODIFICATION OF RNA, PRODUCING AN INCREASED TRANSCRIPT STABILITY AND TRANSLATION EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 18/049593
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049593
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049593 | Modification of RNA, producing an increased transcript stability and translation efficiency | Oct 24, 2022 | Issued |
Array
(
[id] => 18347374
[patent_doc_number] => 20230135484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/047953
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047953
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047953 | METHODS AND COMPOSITIONS FOR EGG WHITE PROTEIN PRODUCTION | Oct 18, 2022 | Abandoned |
Array
(
[id] => 18406075
[patent_doc_number] => 20230167426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => ANTI-CRISPR COMPOUNDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/959019
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959019
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959019 | ANTI-CRISPR COMPOUNDS AND METHODS OF USE | Oct 2, 2022 | Pending |
Array
(
[id] => 18597609
[patent_doc_number] => 20230272406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => 3'-UTR SEQUENCES FOR STABILIZATION OF RNA
[patent_app_type] => utility
[patent_app_number] => 17/936377
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936377 | 3'-UTR sequences for stabilization of RNA | Sep 27, 2022 | Issued |
Array
(
[id] => 18420120
[patent_doc_number] => 20230174581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => PROCESSES AND AGENTS FOR GLAUCOMA
[patent_app_type] => utility
[patent_app_number] => 17/934661
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934661 | PROCESSES AND AGENTS FOR GLAUCOMA | Sep 22, 2022 | Abandoned |
Array
(
[id] => 18193230
[patent_doc_number] => 20230046749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHOD FOR ISOLATING SPECIFIC GENOMIC REGIONS WITH USE OF MOLECULE CAPABLE OF SPECIFICALLY BINDING TO ENDOGENOUS DNA SEQUENCE
[patent_app_type] => utility
[patent_app_number] => 17/823685
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9927
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823685
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823685 | METHOD FOR ISOLATING SPECIFIC GENOMIC REGIONS WITH USE OF MOLECULE CAPABLE OF SPECIFICALLY BINDING TO ENDOGENOUS DNA SEQUENCE | Aug 30, 2022 | Pending |
Array
(
[id] => 19909284
[patent_doc_number] => 12285471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Methods for treating pulmonary disease using inter-alpha inhibitor proteins
[patent_app_type] => utility
[patent_app_number] => 17/821713
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9575
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821713 | Methods for treating pulmonary disease using inter-alpha inhibitor proteins | Aug 22, 2022 | Issued |
Array
(
[id] => 18018170
[patent_doc_number] => 20220369669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHOD FOR PRODUCING HYDROLYSED KERATINACEOUS MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/879291
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879291
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879291 | Method for producing hydrolysed keratinaceous material | Aug 1, 2022 | Issued |
Array
(
[id] => 18207658
[patent_doc_number] => 20230053915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => DIRECTED EDITING OF CELLULAR RNA VIA NUCLEAR DELIVERY OF CRISPR/CAS9
[patent_app_type] => utility
[patent_app_number] => 17/811626
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811626 | Directed editing of cellular RNA via nuclear delivery of CRISPR/Cas9 | Jul 10, 2022 | Issued |